This post was originally published on this site
Also, the growing use of advanced technologies and artificial intelligence to accelerate drug discovery and provide life-transforming treatments should further propel the industry’s growth. Consequently, the global pharmaceuticals market is expected to hit $1,700.97 billion in 2025, growing at an 18% CAGR.
Therefore, we think under-the-radar pharmaceutical stocks Catalyst Pharmaceuticals, Inc. (CPRX), Kamada Ltd . (KMDA), and Opiant Pharmaceuticals, Inc. (OPNT), which have increased their R&D spending significantly, are well-positioned to continue rallying. Hence, it could be wise to bet on these stocks now.